Analysis finds orlistat leads to reduced waist circumference

09/23/2013 | MedPage Today (free registration)

An analysis of multiple studies showed that overweight or obese patients taking orlistat had greater reductions in waist circumference at six and 12 months than did those who took a placebo or had standard care such as lifestyle advice and exercise, U.K. researchers reported on the website of Diabetes, Obesity and Metabolism. Researchers said the use of another drug, lorcaserin, did not have a significant effect on waist circumference.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX